Fortress Biotech, Inc. (FBIO)
1.93
-0.06
(-3.02%)
USD |
NASDAQ |
Oct 23, 16:00
1.915
-0.02
(-0.78%)
After-Hours: 20:00
Fortress Biotech Price : 1.93 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 1.98 | 1.989 | 1.91 | 1.93 | 223618.0 |
| Oct 22, 2026 | 1.94 | 2.01 | 1.93 | 1.99 | 183348.0 |
| Oct 21, 2026 | 1.935 | 1.96 | 1.915 | 1.94 | 178230.0 |
| Oct 20, 2026 | 1.88 | 1.95 | 1.875 | 1.94 | 293949.0 |
| Oct 19, 2026 | 1.88 | 1.89 | 1.83 | 1.87 | 251530.0 |
| Oct 16, 2026 | 1.92 | 1.925 | 1.84 | 1.87 | 264429.0 |
| Oct 15, 2026 | 1.91 | 1.95 | 1.88 | 1.91 | 219467.0 |
| Oct 14, 2026 | 1.93 | 1.945 | 1.88 | 1.90 | 376226.0 |
| Oct 13, 2026 | 2.09 | 2.106 | 1.93 | 1.95 | 443469.0 |
| Oct 12, 2026 | 2.12 | 2.134 | 2.10 | 2.11 | 114121.0 |
| Oct 09, 2026 | 2.12 | 2.17 | 2.09 | 2.135 | 186208.0 |
| Oct 08, 2026 | 2.03 | 2.10 | 2.02 | 2.09 | 265756.0 |
| Oct 07, 2026 | 2.02 | 2.06 | 2.00 | 2.04 | 146198.0 |
| Oct 06, 2026 | 2.09 | 2.132 | 2.02 | 2.05 | 223986.0 |
| Oct 05, 2026 | 2.03 | 2.135 | 2.00 | 2.09 | 553820.0 |
| Oct 02, 2026 | 2.08 | 2.09 | 2.01 | 2.03 | 327172.0 |
| Oct 01, 2026 | 2.17 | 2.17 | 2.07 | 2.07 | 286249.0 |
| Sep 30, 2026 | 2.20 | 2.20 | 2.14 | 2.14 | 221331.0 |
| Sep 29, 2026 | 2.20 | 2.21 | 2.14 | 2.20 | 257166.0 |
| Sep 28, 2026 | 2.26 | 2.270 | 2.17 | 2.17 | 263259.0 |
| Sep 25, 2026 | 2.27 | 2.32 | 2.26 | 2.28 | 264894.0 |
| Sep 24, 2026 | 2.33 | 2.345 | 2.28 | 2.28 | 203678.0 |
| Sep 23, 2026 | 2.445 | 2.445 | 2.33 | 2.34 | 331816.0 |
| Sep 22, 2026 | 2.42 | 2.47 | 2.40 | 2.45 | 199727.0 |
| Sep 21, 2026 | 2.50 | 2.52 | 2.39 | 2.41 | 283345.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Inovio Pharmaceuticals, Inc. | 0.8971 |
| Kura Oncology, Inc. | 9.61 |
| Spero Therapeutics, Inc. | 1.11 |
| ACADIA Pharmaceuticals, Inc. | 19.73 |
| Alnylam Pharmaceuticals, Inc. | 224.03 |
Price Related Metrics
| PE Ratio | 0.7265 |
| PS Ratio | 0.9491 |
| Price to Book Value | 0.3917 |
| Price to Free Cash Flow | 0.5402 |
| Earnings Yield | 137.6% |
| Market Cap | 64.29M |
| Normalized PE Ratio | 0.7882 |